Study the effects of short-term cognitive behavioral therapy (CBT) given by psychiatric nurse practitioners with familiar patients with chronic benzodiazepine use and new patients in the family practice with sleepingdisorders.
ID
Bron
Verkorte titel
Aandoening
sleepingdisorder, slaapstoornissen
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Benzodiazepine use.
Achtergrond van het onderzoek
Study the effects of short-term cognitive behavioral therapy (CBT) given by psychiatric nurse practitioners with familiar patients with chronic benzodiazepine use and new patients in the family practice with sleepingdisorders.
Doel van het onderzoek
Study the effects of short-term cognitive behavioral therapy (CBT) given by psychiatric nurse practitioners with familiar patients with chronic benzodiazepine use and new patients in the family practice with sleepingdisorders.
Onderzoeksopzet
Benzodiazepine gebruik:
Extraction from Electronic Medical System (HIS) (2 times with 3 months interval).
Outcomes related to the sleepingdisorder (2 times with 3 months interval):
1. Pittsburgh Sleep Quality Index (19 items);
2. Insomnia Severity Index (7 items);
3. Self-Efficacy Scale (9 items);
4. Houding en gedachten ten opzichte van de slaap (16 items);
5. Therapy Evaluation Questionnaire (7 items: only interventiongroup);
6. Slaapwaakkalender (only interventiongroup);
7. Slaapevaluatieformulier (6 items: only interventiongroup).
Onderzoeksproduct en/of interventie
Interventiongroup:
Patients in the interventiongroup receive a letter with an invitation to make use of the cognitive behavioral therapy. This include 5 sessions with the POH GGZ en the use of a sleepdiary and a sleepevaluation questionnaire.
The control group receive usual care of sleepdisorders. They don't receive a letter with an invitation and don't get the option of cognitive behavioral therapy and the use of a sleeping diary and sleep evaluation questionnaire. They do complete two times 4 questionnaires (see below) with an interval of 3 months.
Algemeen / deelnemers
Postbus 9101, huispost 114
G. Ven, van de
IQ healthcare
Postbus 9101, huispost 114
Nijmegen 6500 HB
The Netherlands
+31 (0)243616796
G.vandeVen@iq.umcn.nl
Wetenschappers
Postbus 9101, huispost 114
G. Ven, van de
IQ healthcare
Postbus 9101, huispost 114
Nijmegen 6500 HB
The Netherlands
+31 (0)243616796
G.vandeVen@iq.umcn.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Patients familiar with chronic benzodiazepine use;
2. New patients who come to the family practitioner with sleepingdisorders.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Current psychiatric treatment;
2. Drug or alcohol dependency treatment;
3. Psychosis in medical history;
4. Epilepsy;
5. Terminal disease;
6. Not having mastered the Dutch language;
7. Individual family practitioners reasons
severe comorbidity;
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL1843 |
NTR-old | NTR1954 |
Ander register | Stichting Robuust : |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |